Open access
Sep 2026
METTL3-mediated m6A modification of RBM39 promotes cancer stemness and tumor progression in head and neck squamous cell carcinoma
Pan-cancer analysis showed that RBM39 is aberrantly expressed in multiple cancers and is significantly associated with patient prognosis, suggesting its diagnostic value, and RBM39 may serve as a potential diagnostic and therapeutic target for HNSC.
Yu Xin, Wen-Zhi Deng, Chu-Yang Jiang et al.
· Discover Oncology · 0 citations